Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center. [PDF]
Bayeh B +16 more
europepmc +1 more source
Upadacitinib in Rheumatoid Arthritis After Prior TNF Inhibitor Failure: A 12-Month Multicenter Real-World Study. [PDF]
Bakay U, Kaban N.
europepmc +1 more source
Objectives: To compare the congruence of the Disease Activity Score with 28-joint count (DAS-28) with the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) in measuring disease activity in Rheumatoid Arthritis (RA ...
Bhatt, KM +3 more
core
Sex Differences in Treatment Response to Targeted Therapy in Rheumatoid Arthritis: A Post Hoc Analysis of a Prospective Observational Study. [PDF]
Choi SR, Nam E, Sung YK, Cho SK.
europepmc +1 more source
Predictors of intramuscular glucocorticoid bridge therapy failure in rheumatoid arthritis: a real-world observational study. [PDF]
Xie W, Gao D, Huang H, Zhang Z.
europepmc +1 more source
Evaluating the safety and efficacy of equine peripheral blood-derived mesenchymal stem cells in feline chronic gingivostomatitis. [PDF]
de Bouvre N +8 more
europepmc +1 more source
Risk factors for cerebral infarction in patients with rheumatoid arthritis: a retrospective case-control study. [PDF]
Xuan J, Gao X.
europepmc +1 more source
Cellular miRNA-31 and miRNA-125b as predictors of remission and major disease improvement in patients with early rheumatoid arthritis. [PDF]
Horváthová V +9 more
europepmc +1 more source
Whole-blood coagulation and platelet dynamics identify differential prothrombotic states in patients with rheumatoid arthritis treated with JAK or TNF-ɑ inhibitors. [PDF]
Giollo A +9 more
europepmc +1 more source
Serum low-density lipoprotein and synovial vascularity in patients with active rheumatoid arthritis and psoriatic arthritis. [PDF]
Jakubaszek M +3 more
europepmc +1 more source

